Citations

Clear

89 citation(s) found for "Silberstein, SD".

Primary Results of PROMISE-1 (Prevention Of Migraine via Intravenous eptinezumab Safety and Efficacy–1) Trial: a Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for Prevention of Frequent Episo
Saper, Joel R., Kudrow, David, Hirman, Joe, Silberstein, Stephen D., Chakhava, George, Smith, Jeff , Lipton, Richard B. , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s20.001 Get It

Efficacy Of Fremanezumab in Patients With Chronic Migraine With or Without Concomitant Use of Preventive Medication (P4.099)
Silberstein, Stephen D., Yeung, Paul, Blankenbiller, Tricia , Ning, Xiaoping , Yang, Ronghua , Ma, Yuju, Aycardi, Ernesto, Bigal, Marcelo E. , Goadsby, Peter J. , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p4.099 Get It

Erenumab Immunogenicity: a Pooled Analysis of Phase 2 and Phase 3 Migraine Prevention Clinical Trials (P4.098)
Vargas, Bert B., Starling, Amaal J. , Silberstein, Stephen D., Zhou, Yanchen , Trotman, Marie‐Louise, Xue, Fei , Sahebkar-Moghaddam, Farhad, Picard, Hernàn , Mikol, Daniel D.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p4.098 Get It

Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine (P4.093)
Aycardi, Ernesto, Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Silberstein, Stephen D., Dodick, David W. , Goadsby, Peter J.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p4.093 Get It

Conversion from Chronic Migraine (CM) to Episodic Migraine (EM) With Long-Term Erenumab Treatment (S17.008)
Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Cheng, Sunfa , Rippon, Gregory A., Zhang, Feng, Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.s17.008 Get It

Early and Sustained Effect of OnabotulinumtoxinA for Chronic Migraine Treatment: Pooled Analysis of PREEMPT Data (P2.10-018)
Adams, Aubrey Manack, Silberstein, Stephen D., DeGryse, Ronald E., Dodick, David W. , Lipton, Richard B. , Diener, Hans‐Christoph

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-018 Get It

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002)
Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.s26.002 Get It

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)
Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i3.001 Get It

A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)
Starling, Amaal J. , Tepper, Stewart J. , Shamim, Ejaz A. , Hindiyeh, Nada , Silberstein, Stephen D., Marmura, Michael J. , Robbins, Matthew S. , Charles, Andrew , Goadsby, Peter J. , Lipton, Richard B. , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.004 Get It

Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Dodick, David W. , Goadsby, Peter J. , Lipton, Richard B.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.003 Get It